Cargando…

Brain cell type specific proteomics approach to discover pathological mechanisms in the childhood CNS disorder mucolipidosis type IV

Mucolipidosis IV (MLIV) is an ultra-rare, recessively inherited lysosomal disorder resulting from inactivating mutations in MCOLN1, the gene encoding the lysosomal cation channel TRPML1. The disease primarily affects the central nervous system (CNS) and manifests in the first year with cognitive and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sangster, Madison, Shahriar, Sanjid, Niziolek, Zachary, Carisi, Maria Carla, Lewandowski, Michael, Budnik, Bogdan, Grishchuk, Yulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440433/ https://www.ncbi.nlm.nih.gov/pubmed/37609073 http://dx.doi.org/10.3389/fnmol.2023.1215425

Ejemplares similares

Cross-sectional Observations on the Natural History of Mucolipidosis Type IV
por: Misko, Albert L., et al.
Publicado: (2022)

Proteomics analysis of a human brain sample from a mucolipidosis type IV patient reveals pathophysiological pathways
por: Vardi, Ayelet, et al.
Publicado: (2021)

Early evidence of delayed oligodendrocyte maturation in the mouse model of mucolipidosis type IV
por: Mepyans, Molly, et al.
Publicado: (2020)

Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV
por: Misko, Albert L., et al.
Publicado: (2022)

The Dictyostelium Model for Mucolipidosis Type IV
por: Allan, Claire Y., et al.
Publicado: (2022)

Autophagic dysfunction in mucolipidosis type IV patients
por: Vergarajauregui, Silvia, et al.
Publicado: (2008)

Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV
por: Grishchuk, Yulia, et al.
Publicado: (2015)

Unique molecular signature in mucolipidosis type IV microglia
por: Cougnoux, Antony, et al.
Publicado: (2019)

The first genetically confirmed Japanese patient with mucolipidosis type IV
por: Saijo, Harumi, et al.
Publicado: (2016)

Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV
por: Grishchuk, Yulia, et al.
Publicado: (2014)

Systematic Screens for Proteins That Interact with the Mucolipidosis Type IV Protein TRPML1
por: Spooner, Ellen, et al.
Publicado: (2013)

Hip Morphology in Mucolipidosis Type II
por: Ammer, Luise Sophie, et al.
Publicado: (2020)

TPC2 rescues lysosomal storage in mucolipidosis type IV, Niemann–Pick type C1, and Batten disease
por: Scotto Rosato, Anna, et al.
Publicado: (2022)

CNS Manifestations in Mucolipidosis Type II—A Retrospective Analysis of Longitudinal Data on Neurocognitive Development and Neuroimaging in Eleven Patients
por: Ammer, Luise Sophie, et al.
Publicado: (2023)

Mucolipidosis type III, a series of adult patients
por: Oussoren, Esmee, et al.
Publicado: (2018)

Mucolipidosis Type IV in Omani Families with a Novel MCOLN1 Mutation: Search for Evidence of Founder Effect
por: Al-Alawi, Badriya, et al.
Publicado: (2022)

Membrane traffic and turnover in TRP-ML1–deficient cells: a revised model for mucolipidosis type IV pathogenesis
por: Miedel, Mark T., et al.
Publicado: (2008)

New targets for old diseases: lessons from mucolipidosis type II
por: Settembre, Carmine, et al.
Publicado: (2013)

Mucolipidosis Type II Secondary to GNPTAB Gene Deletion from India
por: Gowda, Vykuntaraju K., et al.
Publicado: (2017)

A Novel Mouse Model of a Patient Mucolipidosis II Mutation Recapitulates Disease Pathology
por: Paton, Leigh, et al.
Publicado: (2014)

Neuropathophysiology, Genetic Profile, and Clinical Manifestation of Mucolipidosis IV—A Review and Case Series
por: Jezela-Stanek, Aleksandra, et al.
Publicado: (2020)

Characterization of mesenchymal stem cells in mucolipidosis type II (I-cell disease)
por: KÖSE, Sevil, et al.
Publicado: (2019)

Is hematopoietic stem cell transplantation a therapeutic option for mucolipidosis type II?
por: Ammer, Luise Sophie, et al.
Publicado: (2021)

Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III: A systematic review
por: de Bode, Chiel J., et al.
Publicado: (2022)

DNA Uptake by Type IV Filaments
por: Piepenbrink, Kurt H.
Publicado: (2019)

Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ
por: Idol, Rachel A., et al.
Publicado: (2014)

The mucolipidosis IV Ca(2+) channel TRPML1 (MCOLN1) is regulated by the TOR kinase
por: Onyenwoke, Rob U., et al.
Publicado: (2015)

Correction: Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ
Publicado: (2014)

Case Report: Mucolipidosis II and III Alpha/Beta Caused by Pathogenic Variants in the GNPTAB Gene (Mucolipidosis)
por: Mao, Shao-Jia, et al.
Publicado: (2022)

Severe dilated cardiomyopathy as an unusual finding in a young infant with mucolipidosis type 2
por: Mueller, P, et al.
Publicado: (2006)

Vacuolization of mucolipidosis type II mouse exocrine gland cells represents accumulation of autolysosomes
por: Boonen, Marielle, et al.
Publicado: (2011)

Secondary Hyperparathyroidism in Children with Mucolipidosis Type II (I-Cell Disease): Irish Experience
por: Boruah, Ritma, et al.
Publicado: (2022)

Probing pathomechanisms of mucolipidosis II in fish
Publicado: (2012)

Placental pathology in an unsuspected case of mucolipidosis type II with secondary hyperparathyroidism in a premature infant
por: Wongkittichote, Parith, et al.
Publicado: (2021)

Bilateral carpal tunnel syndrome and multiple trigger fingers in a child with mucolipidosis Type III disease
por: Afshar, Ahmadreza
Publicado: (2011)

Multiplex tandem mass spectrometry enzymatic activity assay for the screening and diagnosis of Mucolipidosis type II and III
por: Hong, Xinying, et al.
Publicado: (2023)

Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer
por: Öhlund, D, et al.
Publicado: (2009)

Type IV Coupling Proteins as Potential Targets to Control the Dissemination of Antibiotic Resistance
por: Álvarez-Rodríguez, Itxaso, et al.
Publicado: (2020)

Mucolipidosis II: first report from Saudi Arabia
por: Alfadhel, Majid, et al.
Publicado: (2013)

Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans
por: Arunkumar, Nivethitha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_la59jcmrkifbu956hiqner12ur